← Organizations
Sponsor / Institution
Shanghai Zhongshan Hospital
Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.
Programs
2
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
2
0 open data checks
Company / Institution Links
0 / 2
industry vs non-industry records
Competitive Density
3
Pipeline Velocity
70
Completion Signal
0
Programs by Stage
Phase 22
Trial / Program Status
Active2
Modality Mix
Steroid/Anti-inflammatory2
Indication Coverage
Hearing Loss2
Sensorineural Hearing Loss1
Sudden Hearing Loss1
Sudden Sensorineural Hearing Loss1
Tinnitus1
Program Types
Therapeutic2
Population Tags
adult2
sensorineural2
sudden2
adolescent1
profound1
salvage-treatment1
steroid1
unilateral1
Strong-Evidence Records
0 recordsNo strong-evidence records are linked to this organization yet.
Checked Records With Caveats
2 checked · 0 open checksFudan Trans-Round Window Intracochlear Steroid Study
Details checked
Steroid/Anti-inflammatoryPhase 2Active
Academic Phase 2 study evaluating glucocorticoid delivery through the round window membrane for profound or complete sudden sensorineural hearing loss. The study compares intracochlear triamcinolone acetonide, intracochlear dexamethasone, and intratympanic dexamethasone; these arms represent one route-and-steroid comparison study rather than separate commercial programs.
Data checks: merged-generated-intervention-arms, institution-led-study
Fudan intracochlear glucocorticoid SSNHL study
Details checked
Steroid/Anti-inflammatoryPhase 2Active
Intracochlear triamcinolone or dexamethasone through the round-window membrane, compared with intratympanic dexamethasone approaches, as salvage treatment for total sudden sensorineural hearing loss.
Data checks: institution-led-study, not-yet-recruiting